These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 23328680)

  • 1. Oral insulin delivery in rats by nanoparticles prepared with non-toxic solvents.
    Viehof A; Javot L; Béduneau A; Pellequer Y; Lamprecht A
    Int J Pharm; 2013 Feb; 443(1-2):169-74. PubMed ID: 23328680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiolated Eudragit nanoparticles for oral insulin delivery: preparation, characterization and in vivo evaluation.
    Zhang Y; Wu X; Meng L; Zhang Y; Ai R; Qi N; He H; Xu H; Tang X
    Int J Pharm; 2012 Oct; 436(1-2):341-50. PubMed ID: 22766443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin.
    Wu ZM; Zhou L; Guo XD; Jiang W; Ling L; Qian Y; Luo KQ; Zhang LJ
    Int J Pharm; 2012 Apr; 425(1-2):1-8. PubMed ID: 22248666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation, characterization, and in vivo evaluation of insulin-loaded PLA-PEG microspheres for controlled parenteral drug delivery.
    Sheshala R; Peh KK; Darwis Y
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1364-74. PubMed ID: 19832637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and characterization of nanoparticles of glibenclamide by solvent displacement method.
    Dora CP; Singh SK; Kumar S; Datusalia AK; Deep A
    Acta Pol Pharm; 2010; 67(3):283-90. PubMed ID: 20524431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery.
    Makhlof A; Tozuka Y; Takeuchi H
    Eur J Pharm Sci; 2011 Apr; 42(5):445-51. PubMed ID: 21182939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin.
    Jain S; Rathi VV; Jain AK; Das M; Godugu C
    Nanomedicine (Lond); 2012 Sep; 7(9):1311-37. PubMed ID: 22583576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of polymers ratio on insulin-loaded nanoparticles based on poly-epsilon-caprolactone and Eudragit RS for oral administration.
    Socha M; Sapin A; Damgé C; Maincent P
    Drug Deliv; 2009 Nov; 16(8):430-6. PubMed ID: 19839787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyethylene glycol as an alternative polymer solvent for nanoparticle preparation.
    Ali ME; Lamprecht A
    Int J Pharm; 2013 Nov; 456(1):135-42. PubMed ID: 23958752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro/in-vivo characterization of trans-resveratrol-loaded nanoparticulate drug delivery system for oral administration.
    Singh G; Pai RS
    J Pharm Pharmacol; 2014 Aug; 66(8):1062-76. PubMed ID: 24779896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microencapsulated chitosan nanoparticles for pulmonary protein delivery: in vivo evaluation of insulin-loaded formulations.
    Al-Qadi S; Grenha A; Carrión-Recio D; Seijo B; Remuñán-López C
    J Control Release; 2012 Feb; 157(3):383-90. PubMed ID: 21864592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
    Essa S; Rabanel JM; Hildgen P
    Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel solid lipid nanoparticles as carriers for oral administration of insulin.
    Zhang Z; Lv H; Zhou J
    Pharmazie; 2009 Sep; 64(9):574-8. PubMed ID: 19827297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of 5-fluorouracil-loaded PLLA-PEG/PEG nanoparticles by a novel supercritical CO2 technique.
    Zhang C; Li G; Wang Y; Cui F; Zhang J; Huang Q
    Int J Pharm; 2012 Oct; 436(1-2):272-81. PubMed ID: 22721846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation, characterization and in vivo evaluation of pH-sensitive oral insulin-loaded poly(lactic-co-glycolicacid) nanoparticles.
    Yang J; Sun H; Song C
    Diabetes Obes Metab; 2012 Apr; 14(4):358-64. PubMed ID: 22151795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of surface charge in targeting pegylated nanoparticles of sulpiride to the brain.
    Parikh T; Bommana MM; Squillante E
    Eur J Pharm Biopharm; 2010 Mar; 74(3):442-50. PubMed ID: 19941957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.
    Zhang Y; Wei W; Lv P; Wang L; Ma G
    Eur J Pharm Biopharm; 2011 Jan; 77(1):11-9. PubMed ID: 20933083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin.
    Zhang N; Ping Q; Huang G; Xu W; Cheng Y; Han X
    Int J Pharm; 2006 Dec; 327(1-2):153-9. PubMed ID: 16935443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin.
    Shan W; Zhu X; Liu M; Li L; Zhong J; Sun W; Zhang Z; Huang Y
    ACS Nano; 2015 Mar; 9(3):2345-56. PubMed ID: 25658958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.